Sentio BioSciences LLC

Form 483 issued April 19, 2019 · Maryland Heights, Missouri

Inspection
Apr 10 – Apr 19, 2019
Observations
3
Pages
3
FEI number
3007640515

In short: On April 19, 2019, FDA issued a Form 483 with 3 observations to Sentio BioSciences LLC in Maryland Heights, Missouri (FEI 3007640515) after an inspection that ran Apr 10 – Apr 19, 2019. The investigator was Tiara N. Brown-Crosen. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

3 of 3 observations on this 483 concern production.

Production3

Most cited: 21 CFR 211.100 (2×) · 211.186 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written procedures for the qualification of equipment fail to include specific details of the…

  2. 02

    Written procedures approved by the quality unit are not follow and do not always include sufficient…

  3. 03

    Failure to include label specimens…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sentio BioSciences LLC?

FDA listed 3 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Sentio BioSciences LLC?

Tiara N. Brown-Crosen is named on this Form 483, for the inspection of Apr 10 – Apr 19, 2019. Each investigator has a profile showing what they cite most.

When was Sentio BioSciences LLC inspected by FDA?

The inspection ran Apr 10 – Apr 19, 2019, and the Form 483 is dated April 19, 2019.

How do I get the full Form 483 for Sentio BioSciences LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free